Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index; 7 of the 61 sources its claims cite were checked for support.

Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy

Open access
Miller, Walter L, Pandey, Amit V, Flück, Christa E · 2025 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Most disorders of steroidogenesis, such as forms of congenital adrenal hyperplasia (CAH) are caused by mutations in genes encoding the steroidogenic enzymes and are often recognized clinically by cortisol deficiency, hyper- or hypo-androgenism, and/or altered mineralocorticoid function. Most steroidogenic enzymes are forms of cytochrome P450. Most P450s, including several steroidogenic enzymes, are microsomal, requiring electron donation by P450 oxidoreductase (POR); however, several steroidogenic enzymes are mitochondrial P450s, requiring electron donation via ferredoxin reductase (FDXR) and ferredoxin (FDX). POR deficiency is a rare but well-described form of CAH characterized by impaired activity of 21-hydroxylase (P450c21, CYP21A2) and 17-hydroxylase/17,20-lyase (P450c17, CYP17A1); more severely affected individuals also have the Antley-Bixler skeletal malformation syndrome and disordered genital development in both sexes, and hence is easily recognized. The 17,20-lyase activity of P450c17 requires both POR and cytochrome b5 (b5), which promote electron transfer. Mutations of POR, b5, or P450c17 can cause selective 17,20-lyase deficiency. In addition to providing electrons to mitochondrial P450s, FDX, and FDXR are required for the synthesis of iron-sulfur clusters, which are used by many enzymes. Recent work has identified FDXR mutations in patients with visual impairment, optic atrophy, neuropathic hearing loss, and developmental delay, resembling the global neurologic disorders seen with mitochondrial diseases. Many of these patients have had life-threatening events or deadly infections, often without an apparent triggering event. Adrenal insufficiency has been predicted in such individuals but has only been documented recently. Neurologists, neonatologists, and geneticists should seek endocrine assistance in evaluating and treating patients with mutations in FDXR.

Overview

CoChat Summary

TL;DR

This paper is a narrative review of “electron transfer” defects in steroidogenesis, focusing on POR, cytochrome b5, FDX1/FDX2, and especially FDXR as causes of CAH-like disease and mitochondriopathy. Its main clinical warning is that severe FDXR deficiency can include potentially lethal adrenal insufficiency, which should be actively evaluated in affected patients.

Key findings

  • POR deficiency is a well-established cause of disordered steroidogenesis and skeletal malformations: the review states that >200 POR mutations have been reported in >250 patients, and that more severe mutations cause Antley-Bixler syndrome, while mutations retaining ~20% to 40% activity may cause “nonclassic POR deficiency.”
  • Cytochrome b5 deficiency is rare but can cause isolated 17,20-lyase deficiency and methemoglobinemia; the paper notes that most reported cases involved 46,XY DSD, with one 24-year-old woman homozygous for b5 Y35X reported as having normal development and fertility despite methemoglobinemia.
  • Human FDXR deficiency had, by 2017–2023, at least 77 patients from >50 families with 59 different biallelic mutations, presenting with optic atrophy, retinal dystrophy, neuropathic hearing loss, developmental delay, movement disorders, and Leigh syndrome; in one hereditary optic neuropathy cohort, 5/434 patients with autosomal disease had FDXR mutations, and all 5 also had deafness.
  • The review highlights a newly recognized endocrine consequence of FDXR deficiency: in a recent study, 2 severely affected siblings with FRM had adrenal insufficiency and a steroid pattern suggesting 11-hydroxylase deficiency, and review of prior FRM cases found severe or life-threatening events/infections suggestive of adrenal insufficiency in 20/77 (26%) patients.

Methods

  • Narrative review of published literature on electron-transfer proteins required for steroidogenic mitochondrial and microsomal cytochrome P450 enzymes.
  • Synthesizes human genetic, biochemical, cell-culture, and animal-model findings for POR, cytochrome b5, FDX1, FDX2, and FDXR.
  • Uses reported case series and cohort studies to summarize phenotypes, mutation counts, and endocrine consequences.

Limitations

  • Not stated in the paper.
  • Evident from the text: this is a brief review, not a new cohort study or systematic review, so the strength of conclusions depends on heterogeneous prior reports.
  • Evident from the text: for some genes/disorders the evidence remains incomplete—e.g., no human FDX1 mutation has yet been reported, and studies of steroidogenesis were not done in the reported FDX2 cases.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgae815

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Simplified steroidogenic pathway. Only the human cytochrome P450 enzymes are shown; for figures showing all steroidogenic enzymes and other pathways, see (1). The “microsomal” (type 2) steroidogenic P450 enzymes are: P450c17 (17α-hydroxylase/17,20-lyase; CYP17A1), P450c21 (21-hydroxylase, CYP21A1), and P450aro (aromatase, CYP19A1); these 3 enzymes require electron donation from P450 oxidoreductase (POR). The 17,20-lyase activity of P450c17 is minimal in the absence of cytochrome b5 (b5). The mitochondrial (type 1) steroidogenic P450 enzymes are: P450scc (cholesterol side-chain cleavage enzyme, CYP11A1), P450c11β (11β-hydroxylase, CYP11B1), and P450c11AS (aldosterone synthase, CYP11B2); these 3 enzymes require electron donation via ferredoxin (FDX) and ferredoxin reductase (FDXR). CYP11B2 catalyzes the 3 terminal steps (11-hydroxylation, 18-hydroxylation, and 18-methyl oxidase activity) in the production of aldosterone (Aldo) from deoxycorticosterone (DOC); each of these steps requires a pair of electrons donated from NADPH via FDX and FDXR.
Figure 1. Simplified steroidogenic pathway. Only the human cytochrome P450 enzymes are shown; for figures showing all steroidogenic enzymes and other pathways, see (1). The “microsomal” (type 2) steroidogenic P450 enzymes are: P450c17 (17α-hydroxylase/17,20-lyase; CYP17A1), P450c21 (21-hydroxylase, CYP21A1), and P450aro (aromatase, CYP19A1); these 3 enzymes require electron donation from P450 oxidoreductase (POR). The 17,20-lyase activity of P450c17 is minimal in the absence of cytochrome b5 (b5). The mitochondrial (type 1) steroidogenic P450 enzymes are: P450scc (cholesterol side-chain cleavage enzyme, CYP11A1), P450c11β (11β-hydroxylase, CYP11B1), and P450c11AS (aldosterone synthase, CYP11B2); these 3 enzymes require electron donation via ferredoxin (FDX) and ferredoxin reductase (FDXR). CYP11B2 catalyzes the 3 terminal steps (11-hydroxylation, 18-hydroxylation, and 18-methyl oxidase activity) in the production of aldosterone (Aldo) from deoxycorticosterone (DOC); each of these steps requires a pair of electrons donated from NADPH via FDX and FDXR.CC BY · PubMed Central
Figure 2. Diagrams of the cell biology of electron transfer to P450 enzymes. A, Microsomal (type 2) P450 enzymes. Both POR and the P450 are bound to the cytoplasmic aspect (CYTO) of the endoplasmic reticulum (ER). POR has 2 “wings,” one containing a flavin adenine dinucleotide (FAD) and one containing a flavin mononucleotide (FMN). NADPH interacts with and donates a pair of electrons to the FAD moiety. Electron receipt by the FAD elicits a conformational change, permitting the isoalloxazine rings of the FAD and FMN moieties to come sufficiently close together to permit the electrons to move from the FAD to the FMN. Electron receipt by the FMN permits the POR protein to revert to its original, open conformation; this permits the FMN domain to “dock” with the redox-partner binding site of the P450 by charge-charge interactions. The electrons reach the iron atom of the heme group of the P450, mediating catalysis. For some P450 reactions, notably the 17,20-lyase activity of human P450c17, cytochrome b5 promotes increased activity. B, Mitochondrial (type 1) P450 enzymes. Both ferredoxin reductase (FDXR) and the P450 are bound to the inner mitochondrial membrane, but ferredoxin (FDX) is not. NADPH donates a pair of electrons to the FAD moiety of FDXR; which then donates them to the 2Fe2S center of FDX (represented by the ball-and-stick glyph). The same surface of FDX interacts with both the FAD of FDXR and the redox-partner binding site of the P450 by electrostatic interactions. FDX thus acts as an indiscriminate electron-shuttling protein that can support the catalysis of any available type 1 P450. The electrons reach the heme iron of the P450 permitting catalysis.
Figure 2. Diagrams of the cell biology of electron transfer to P450 enzymes. A, Microsomal (type 2) P450 enzymes. Both POR and the P450 are bound to the cytoplasmic aspect (CYTO) of the endoplasmic reticulum (ER). POR has 2 “wings,” one containing a flavin adenine dinucleotide (FAD) and one containing a flavin mononucleotide (FMN). NADPH interacts with and donates a pair of electrons to the FAD moiety. Electron receipt by the FAD elicits a conformational change, permitting the isoalloxazine rings of the FAD and FMN moieties to come sufficiently close together to permit the electrons to move from the FAD to the FMN. Electron receipt by the FMN permits the POR protein to revert to its original, open conformation; this permits the FMN domain to “dock” with the redox-partner binding site of the P450 by charge-charge interactions. The electrons reach the iron atom of the heme group of the P450, mediating catalysis. For some P450 reactions, notably the 17,20-lyase activity of human P450c17, cytochrome b5 promotes increased activity. B, Mitochondrial (type 1) P450 enzymes. Both ferredoxin reductase (FDXR) and the P450 are bound to the inner mitochondrial membrane, but ferredoxin (FDX) is not. NADPH donates a pair of electrons to the FAD moiety of FDXR; which then donates them to the 2Fe2S center of FDX (represented by the ball-and-stick glyph). The same surface of FDX interacts with both the FAD of FDXR and the redox-partner binding site of the P450 by electrostatic interactions. FDX thus acts as an indiscriminate electron-shuttling protein that can support the catalysis of any available type 1 P450. The electrons reach the heme iron of the P450 permitting catalysis.CC BY · PubMed Central

Verification

Claims the paper makes

7 Valid · 0 Not valid · 26 Not checked · 9 Own results and interpretations

7 more claims

Create a free account to see all 42 claims and to verify the 54 references still open.

See all claims — free account
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 2

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

1 retracted

Show all 117 references

Cited by

See all 17

Metadata

Authors
Miller, W. L., Pandey, A. V., & Flück, C. E.
Affiliations
  • University of California, San Francisco (US)
  • University of Bern (CH)
  • Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern , Bern 3010 ,
Corresponding author
Miller, Walter L
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-11-22
Volume
110
Issue
3
Pages
e574-e582
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4404642664
Cited by
17
References
117
Citations by year
2026: 9 · 2025: 8
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open Access CRIS of the University of Bern
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
steroidogenesis, congenital adrenal hyperplasia, P450 oxidoreductase deficiency, ferredoxin reductase, ferredoxin, cytochrome b5, 17,20-lyase deficiency, CYP17A1, CYP21A2, mitochondrial disease, mitochondrial neurogastrointestinal encephalomyopathy, adrenal insufficiency, mitochondrial DNA mutations, iron-sulfur clusters
MeSH terms
Adrenal Hyperplasia, Congenital, Cytochrome P-450 Enzyme System, Electron Transport, Humans, Mitochondria, Steroid 17-alpha-Hydroxylase, Steroids, Mitochondrial Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy. https://app.cochat.ai/papers/10.1210/clinem/dgae815
The paper
Miller, W. L., Pandey, A. V., & Flück, C. E. (2025). Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.